Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Onkologie|December 1, 1988
[Hepatotoxicity with etoposide-ifosfamide combination therapy]R Paschke, P Worst, J Brust, et al.
Deutsche Medizinische Wochenschrift (1946)|October 4, 1985
[Hyperimmunoglobulinemia E, recurring staphylococcal infections and a defect in granulocyte chemotaxis in adults. A variant of Job's syndrome]M E Heim, R Herz, P Worst, et al.
Deutsche Medizinische Wochenschrift (1946)|May 27, 1988
[Idiopathic familial erythrocytosis. Report on a family with autosomal dominant inheritance]W Queisser, M E Heim, J M Schmitz, et al.
Onkologie|August 1, 1989
Sequential high dose methotrexate, 5-fluorouracil and folinic acid does not improve response rates in advanced colorectal cancerM E Heim, D Schuster, H Flechtner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ifosfamide/etoposide and mesna uroprotection in advanced breast cancerC Manegold, P Worst, J Bickel, et al.
Onkologie|February 1, 1991
Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer SocietyK Possinger, H Wagner, P Worst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2006
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study GroupB Klimm, H T Eich, H Haverkamp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)V Ballova, J-U Rüffer, H Haverkamp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study GroupM Sieber, H Bredenfeld, A Josting, et al.
Blood|December 9, 1998
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study GroupH Tesch, V Diehl, B Lathan, et al.
Pageof 2